Cyclophosphamide- Antifungals Interactions in Patients Undergoing Hematopoietic Stem Cell Transplantation: What Should We Know about It?
作者信息
Zarrabi Sogol, Vaezi Mohammad, Shahrami Bita
机构信息
Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Hematology, Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran.
出版信息
Int J Hematol Oncol Stem Cell Res. 2024 Jul 1;18(3):306-310. doi: 10.18502/ijhoscr.v18i3.16112.
Abstract
摘要
相似文献
1
Cyclophosphamide- Antifungals Interactions in Patients Undergoing Hematopoietic Stem Cell Transplantation: What Should We Know about It?造血干细胞移植患者中环磷酰胺与抗真菌药物的相互作用：我们对此应了解些什么？
Int J Hematol Oncol Stem Cell Res. 2024 Jul 1;18(3):306-310. doi: 10.18502/ijhoscr.v18i3.16112.
2
Drug-drug interactions in patients undergoing hematopoietic stem cell transplantation: systematic review.造血干细胞移植患者的药物-药物相互作用：系统评价。
Farm Hosp. 2021 Jun 3;45(4):184-192. doi: 10.7399/fh.11627.
3
Drug interactions of tacrolimus with letermovir and azole antifungals following hematopoietic stem cell transplantation: A retrospective observational analysis.他克莫司与来特莫韦和唑类抗真菌药在造血干细胞移植后的药物相互作用：一项回顾性观察性分析。
Pharmacol Res Perspect. 2023 Aug;11(4):e01120. doi: 10.1002/prp2.1120.
4
Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease after Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide: A Study on Behalf of the Spanish Hematopoietic Stem Cell Transplantation and Cellular Therapy Group (GETH).未预处理单倍体造血干细胞移植后应用环磷酰胺治疗的窦状隙阻塞综合征/静脉闭塞病：西班牙造血干细胞移植和细胞治疗组（GETH）的一项研究。
Transplant Cell Ther. 2024 Sep;30(9):914.e1-914.e8. doi: 10.1016/j.jtct.2024.06.003. Epub 2024 Jun 7.
5
Busulfan plus fludarabine as a myeloablative conditioning regimen compared with busulfan plus cyclophosphamide for acute myeloid leukemia in first complete remission undergoing allogeneic hematopoietic stem cell transplantation: a prospective and multicenter study.在接受异基因造血干细胞移植的首次完全缓解的急性髓系白血病患者中，与白消安加环磷酰胺相比，白消安加氟达拉滨作为清髓性预处理方案：一项前瞻性多中心研究。
J Hematol Oncol. 2013 Feb 8;6:15. doi: 10.1186/1756-8722-6-15.
6
Association between potential drug interactions and clinical outcomes in hematopoietic stem cell transplantations.
J Oncol Pharm Pract. 2019 Jul;25(5):1105-1111. doi: 10.1177/1078155218775195. Epub 2018 May 21.
7
Important drug interactions in hematopoietic stem cell transplantation: what every physician should know.造血干细胞移植中的重要药物相互作用：每个医生都应该知道的知识。
Biol Blood Marrow Transplant. 2012 Jul;18(7):989-1006. doi: 10.1016/j.bbmt.2011.11.029. Epub 2011 Dec 7.
8
Incidence, features, and outcomes of cytomegalovirus DNAemia in unmanipulated haploidentical allogeneic hematopoietic stem cell transplantation with post-transplantation cyclophosphamide.在采用移植后环磷酰胺的非处理单倍体相合异基因造血干细胞移植中巨细胞病毒血症的发生率、特征及结局
Transpl Infect Dis. 2020 Feb;22(1):e13206. doi: 10.1111/tid.13206. Epub 2019 Nov 15.
9
How we perform haploidentical stem cell transplantation with posttransplant cyclophosphamide.如何进行亲缘单倍体干细胞移植并使用移植后环磷酰胺。
Hematology Am Soc Hematol Educ Program. 2019 Dec 6;2019(1):513-521. doi: 10.1182/hematology.2019001323.
10
Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus.非清髓性造血干细胞移植治疗系统性红斑狼疮。
JAMA. 2006 Feb 1;295(5):527-35. doi: 10.1001/jama.295.5.527.
本文引用的文献
1
When Azoles Cannot Be Used: The Clinical Effectiveness of Intermittent Liposomal Amphotericin Prophylaxis in Hematology Patients.当无法使用唑类药物时：间歇性脂质体两性霉素预防在血液病患者中的临床疗效
Open Forum Infect Dis. 2021 Mar 8;8(7):ofab113. doi: 10.1093/ofid/ofab113. eCollection 2021 Jul.
2
Plausible drug interaction between cyclophosphamide and voriconazole via inhibition of CYP2B6.推测环磷酰胺和伏立康唑之间可能存在药物相互作用，通过抑制 CYP2B6 实现。
Drug Metab Pharmacokinet. 2021 Aug;39:100396. doi: 10.1016/j.dmpk.2021.100396. Epub 2021 Apr 12.
3
Low-dose liposomal amphotericin B for antifungal prophylaxis in paediatric allogeneic haematopoietic stem cell transplantation.低剂量脂质体两性霉素B用于儿童异基因造血干细胞移植的抗真菌预防
J Antimicrob Chemother. 2020 Aug 1;75(8):2264-2271. doi: 10.1093/jac/dkaa149.
4
Inhaled Amphotericin B as Aspergillosis Prophylaxis in Hematologic Disease: An Update.吸入两性霉素B用于血液系统疾病曲霉病预防的最新进展
Microbiol Insights. 2019 Aug 28;12:1178636119869937. doi: 10.1177/1178636119869937. eCollection 2019.
5
A high-specificity immunoassay for the therapeutic drug monitoring of cyclophosphamide.一种用于环磷酰胺治疗药物监测的高特异性免疫分析法。
Analyst. 2019 Aug 16;144(17):5172-5178. doi: 10.1039/c9an00576e.
6
Managing Drug Interactions in Cancer Therapy: A Guide for the Advanced Practitioner.癌症治疗中的药物相互作用管理：高级从业者指南
J Adv Pract Oncol. 2017 Sep-Oct;8(6):609-620. Epub 2017 Sep 1.
7
Drug safety assessment of oral formulations of ketoconazole.酮康唑口服制剂的药物安全性评估
Expert Opin Drug Saf. 2015 Feb;14(2):325-34. doi: 10.1517/14740338.2015.983071. Epub 2014 Nov 20.
8
Potential drug interactions and chemotoxicity in older patients with cancer receiving chemotherapy.老年癌症患者接受化疗时的潜在药物相互作用和化学毒性。
J Geriatr Oncol. 2014 Jul;5(3):307-14. doi: 10.1016/j.jgo.2014.04.002. Epub 2014 May 10.
9
Fluconazole coadministration concurrent with cyclophosphamide conditioning may reduce regimen-related toxicity postmyeloablative hematopoietic cell transplantation.在进行清髓性造血细胞移植时，氟康唑与环磷酰胺预处理同时使用，可能会降低与治疗方案相关的毒性。
Biol Blood Marrow Transplant. 2007 Jul;13(7):760-4. doi: 10.1016/j.bbmt.2007.03.005. Epub 2007 Apr 30.
10
Clinical pharmacokinetics of cyclophosphamide.环磷酰胺的临床药代动力学
Clin Pharmacokinet. 2005;44(11):1135-64. doi: 10.2165/00003088-200544110-00003.
Zotero 插件